Team8 is not your typical Israeli venture capital firm. Alongside classic investments, it builds companies from scratch, a Venture Creation model, and operates a dedicated digital health practice backed by a roughly $70 million fund. Its current portfolio includes at least eight digital health companies, all focused on improving the administrative and operational infrastructure of the U.S. healthcare system.

Here's a closer look at each company and why they matter now.

Fijoya: AI-Powered Employer Healthcare Benefits

Fijoya is an AI-driven employee benefits platform that connects employers to 200+ health and wellness services, mental health, nutrition, family planning, and lets employees choose their own benefits through personalized AI navigation instead of a fixed plan.

The company raised $8.3 million in seed funding in March 2024, led by Team8, with a pay-per-use business model. Founders are Baruch Levy (CEO) and Sagi Polani (CPO). In November 2025, Fijoya announced a strategic partnership with The ICHRA Shop, becoming the technology backbone for ICHRA (Individual Coverage Health Reimbursement Arrangement) programs, giving employers a defined-contribution alternative to traditional group insurance. It is SOC 2 Type 2 certified and HIPAA compliant.

Popai Health: Voice AI That Listens to Patient Calls

Popai Health emerged from stealth in November 2025 with an $11 million seed round led by Team8 and NEA, with participation from Town Hall Ventures and Essen Health Care. The platform uses voice AI to automatically analyze patient phone conversations, documenting 100% of calls, extracting clinical and operational insights, generating compliant notes, and triggering automated follow-up actions.

Team8 built Popai from the ground up, operating on the thesis that "phone conversations are the largest untapped data source in healthcare." The company is headquartered in San Francisco with Israeli roots, focusing on transitions of care and chronic care management.

Dimer Health: Hospital-to-Home, with AI and Clinical Support

Dimer Health is a clinician-led, AI-native company focused on transitional care medicine, the critical 30 days after hospital discharge when most costly readmissions occur. The platform combines 24/7 virtual clinical support with an AI companion called AiME that proactively monitors and guides patients through recovery.

In March 2026, Dimer Health raised $13.5 million in Series A funding led by Team8 and Bill Ackman's Table Management, with participation from Silver Circle and TechAviv. Total funding to date is approximately $20 million. In 2025, the company launched a pilot with RWJBarnabas Health in New Jersey, one of the largest healthcare systems in the U.S. Founders: Caroline Hodge (CEO), Gidon Coussin (CSO), and Sarig Reichert (CPO).

FlowRx: AI for Independent Pharmacies

FlowRx was founded in May 2025 by Eran Shavelsky, a serial entrepreneur who previously built MedMinder. The company brings deterministic AI workflow automation to independent pharmacies in the U.S., handling prescription processing, billing, prior authorizations, inventory management, and other repetitive tasks that consume roughly 40% of pharmacists' time.

The system sits on top of existing pharmacy infrastructure with zero integration hassle, designed to reduce errors, ease acute staffing shortages, and protect thinning margins. Team8 backed FlowRx from inception as a portfolio company. Shavelsky holds an MBA from MIT.

Briya: AI for Medical Research

Briya is a decentralized healthcare data platform that gives researchers, hospitals, and life sciences companies access to real-world clinical data without moving or duplicating it. The platform supports FHIR/OMOP standards and is HIPAA and GDPR compliant.

Briya launched Briya AIRE, described as the first clinical-grade AI research environment. Users can run studies, segment patient cohorts, and analyze trends using natural language, turning months of manual work into seconds. The company raised $11.5 million in Series A and is backed by Team8, Insight Partners, Aleph, and CRV, with CEO David Lazerson at the helm.

OneStep: Gait as the Sixth Vital Sign

OneStep turns any smartphone into a clinical gait lab, extracting 30+ mobility parameters from a patient's natural movement, no wearables, no sensors, no calibration required. The platform delivers fall-risk scores, post-surgery recovery tracking, and remote therapeutic monitoring for senior living, orthopedics, and physical therapy.

The company raised $36 million in Series B in October 2024 led by Team8, totaling roughly $48 million in disclosed funding. It reports 200,000+ patients treated and 35+ billion steps analyzed. In March 2026, OneStep announced a strategic partnership with Protonics to combine gait analysis with neuromuscular re-education technology in an "assess-and-correct" ecosystem.

Bluespine: Fighting Medical Overbilling with AI

Bluespine is an AI-powered payment integrity platform targeting self-insured employers. The system analyzes medical and pharmacy claims to detect overbilling, coding errors, and improper payments, a problem that costs U.S. employers hundreds of billions annually. In case studies, Bluespine delivered up to 10% savings on annual healthcare spend.

Bluespine raised $7.2 million in seed funding in November 2024 led by Team8. The company is actively hiring across AI engineering, data infrastructure, and customer success roles through 2026.

C8 Health: AI for Clinical Knowledge Management

C8 Health runs a cloud-based platform that centralizes hospitals' clinical protocols, guidelines, and quality data, making them instantly accessible to clinicians at the point of care via an AI assistant called Panda. The goal: bridge the gap between established best practices and real-world care delivery.

In July 2025, C8 Health raised a $12 million Series A led by Team8, with participation from 10D and Vertex Ventures Israel. Founded in 2021, the company operates in both the U.S. and Israel.

Why Now?

Team8 Health has largely flown under the radar, but 2025–2026 marks a notable acceleration. In the second half of 2025 alone, Popai, FlowRx, and C8 Health all emerged with significant funding rounds, and Dimer Health closed its Series A with Bill Ackman in March 2026.

The firm also operates the "Digital Health Innovation Village", a network of 100+ health system executives who advise portfolio companies. Team8's Venture Creation model, originally built for cybersecurity, translates well to digital health: companies are built inside the firm with shared infrastructure, customer access, and seasoned management from day one, not after a check is cut.

The Bottom Line

Team8's digital health portfolio paints a clear picture: AI in healthcare is moving from marketing to execution. Every company in the portfolio tackles a defined operational problem, overbilling, inconsistent protocols, unsafe hospital discharge, stressed pharmacies, administrative burden on clinicians.

What they have in common: none of them sell cure-all fantasies. They fix the plumbing, and the U.S. market has never been more ready for it.

This article is for informational purposes only and does not constitute investment advice. Nothing in this article should be construed as a recommendation to buy, sell, or hold any securities. The author does not hold positions in any of the companies mentioned and has received no compensation from them.